Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Parexel International's peak revenue was $2.4B in 2017. The peak quarterly revenue was $647.6M in 2017(q4).
Parexel International's revenue increased from $671.5m in 2005 to $2.4B currently. That's a 263.57% change in annual revenue.
| Fiscal year / year | Parexel International revenue |
|---|---|
| 2009 | $1.2B |
| 2010 | $1.3B |
| 2011 | $1.4B |
| 2012 | $1.6B |
| 2013 | $2.0B |
| 2014 | $2.3B |
| 2015 | $2.3B |
| 2016 | $2.4B |
| 2017 | $2.4B |
How accurately did Parexel International's revenue projections match actual performance?
Parexel International saw the greatest revenue growth in 2008, when revenue increased by 26.67%.
Parexel International had the lowest revenue growth in 2017, when revenue changed by 0.63%.
| Year | Parexel International growth |
|---|---|
| 2009 | 7%↑ |
| 2010 | 7%↑ |
| 2011 | 6%↑ |
| 2012 | 14%↑ |
| 2013 | 23%↑ |
| 2014 | 14%↑ |
| 2015 | 3%↑ |
| 2016 | 4%↑ |
| 2017 | 1%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $319.6M | $324.0M | $311.0M | $292.4M |
| 2010 | $307.5M | $338.0M | $344.4M | $346.0M |
| 2011 | $342.3M | $364.1M | $353.0M | $363.2M |
| 2012 | $360.6M | $387.8M | $412.0M | $457.7M |
| 2013 | $462.5M | $483.1M | $523.5M | $526.9M |
| 2014 | $529.1M | $574.2M | $577.9M | $585.2M |
| 2015 | $573.7M | $575.0M | $576.4M | $605.2M |
| 2016 | $585.2M | $604.2M | $611.4M | $625.5M |
| 2017 | $576.5M | $612.2M | $605.2M | $647.6M |
Do you work at Parexel International?
Did Parexel International meet its revenue projections?
| CEO | Jamie MacDonald |
| Industry | Commercial & Professional Services |
| Company Type | Public |
| Employees Number | 18,900 |
| Date Founded | 1983 |
| Headquarters | Waltham, Massachusetts |
| Number of Locations | 14 |
| Revenue | $2.4B |
| Net Income | $107,300,000 |
| Gross Proft | $740.1M (2017) |
| EBITDA | $274.9M (2017) |
| PE Ratio | 41.94 |
| Tax Rate | 0.3% |
| Market Capitalization | $4.5B |
| Total Assets | $2,313,400,000 |
| Ticker | PRXL |
Parexel International's top competitor, Pfizer, earned an annual revenue of $63.6B.
Parexel International's smallest competitor is Globin Solutions with revenue of $39.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Firma Clinical Research | $64,818 | $2.6M | 119 | - |
| Criterium | $53,133 | $9.3M | 50 | - |
| Globin Solutions | $44,823 | $39,000 | 1 | - |
| ExecuPharm | $93,794 | $76.0M | 750 | - |
| Charles River Labs | $45,905 | $4.0B | 18,400 | 492 |
| Pharmaceutical Research Associates, Inc. | $77,178 | $30.0M | 30 | 7 |
| Covance | $64,568 | $2.6B | 50,000 | - |
| PRA Health Sciences | $60,810 | $3.2B | 17,000 | - |
| Pharmaceutical Product Development | $69,995 | $65.0M | 21,000 | - |
| Medpace | $69,547 | $2.1B | 2,800 | 231 |
Zippia gives an in-depth look into the details of Parexel International, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Parexel International. The employee data is based on information from people who have self-reported their past or current employments at Parexel International. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Parexel International. The data presented on this page does not represent the view of Parexel International and its employees or that of Zippia.
Parexel International may also be known as or be related to PAREXEL, PAREXEL INTERNATIONAL CORP, PAREXEL International Clinical Research Pvt. Ltd., PAREXEL International Corporation, Parexel, Parexel International, Parexel International Corporation and Parexel International, LLC.